08/04/2026 | News release | Distributed by Public on 08/04/2026 09:06
ARUP Laboratories' experts will share their insights on immunopathology at the upcoming 2026 Association of Medical Laboratory Immunologists (AMLI) Annual Meeting, covering topics such as emerging infectious diseases, recent advances in fungal diagnostics, and neuroimmunology biomarkers.
The conference will take place August 13-16, 2026, in Salt Lake City, and will offer attendees the opportunity to tour ARUP as well.
Refer to the information below for the full schedule of ARUP experts' presentations and posters.
Representatives from ARUP will also be available at booth #3 in the exhibition hall, located in the Grand Ballroom, during coffee breaks.
10:15 a.m. Meet the Exhibitors/Coffee Break
2:30 p.m. Meet the Exhibitors/Coffee Break
5:30 p.m. Tour of ARUP Laboratories
9:40 a.m. Emerging Infectious Diseases and Public Health Aspects
Benjamin Bradley, MD, PhD, Head of Clinical Operations for Infectious Disease
10:15 a.m. Meet the Exhibitors/Coffee Break
10:45 a.m. Beyond Culture: Recent Advances and Future Needs in Fungal Diagnostics
Kimberly Hanson, MD, MHS, Medical Director of Mycology
3:00 p.m. Meet the Exhibitors/Coffee Break
4:30 p.m. Neural Antibody Testing: Fabulous, Flummoxing, and Faulty
Tammy Smith, MD, PhD, Clinical Consultant in Autoimmune Neurology
5:00 p.m. Poster Session/Meet the Exhibitors
10:00 a.m. Meet the Exhibitors/Coffee Break
2:30 p.m. Bridging to Heart Transplant, While Igniting Antibodies: Cardiac Assist Devices and HLA Allosensitization
Arevik Ghazaryan, PhD, Immunology Fellow, Future Leaders Award Honoree
5:00 p.m. Poster Session/Meet the Exhibitors
10:00 a.m. Meet the Exhibitors/Coffee Break
11:00 a.m. Evaluation of Serum Tryptase Reference Intervals Using an Indirect Method
Abdulrahman Saadalla, MB, BCh, Medical Director of the Immunology Core Lab and Coagulation
Board 2-Transplant Immunology: Bridging to Heart Transplant, While Igniting Antibodies: Cardiac Assist Devices and HLA Allosensitization
Board 15-Other: Clinical Validation of Capillary Serum Tryptase To Enable Direct-to-Patient Testing
Board 21-Infectious Disease: Comparison of Two Chagas ELISA Assays Used in Tandem Testing Algorithm
Board 22-Infectious Disease: Validation of an Antibody Index Assay for the Diagnosis of Lyme Neuroborreliosis
Board 23-Transplant Immunology: Comparative Evaluation of Analytical Performance and Workflow Characteristics of Sequencing-Based Chimerism Assays for Post-Transplant Monitoring Across Diverse Clinical Scenarios
Board 24-Autoimmune Disease: Performance Evaluation of MosaiQ AiPlex® Vasculitis (VAS) Assay for the Detection of MPO, PR3, and GBM Antibodies
Board 29-Other: Conversion of Lymphocyte Subsets Assay From 3 to 1 Tube Format
Board 35-Infectious Disease: Analytical Validation of the Tasso+ Device for Remote HCV Antibody and RNA Testing in Capillary Blood To Improve Diagnosis in Remote and Austere Conditions
Board 48-Autoimmune Disease: Method Comparison Between the Investigational Use Only MosaiQ AiPlex Celiac Disease Microarray Immunoplex Assay to the Aptiva
Board 64-Other: Validation of a Basophil Activation Test for the Assessment of Peanut Allergy in a Clinical Laboratory Setting
Board 65-Autoimmune Disease: The Clinical Utility of Elevated DGP-IgA Antibodies in the Diagnosis of Celiac Disease
Alice To, [email protected]